Respondents from China were the most likely to say they'd get a vaccine once available. Image: REUTERS/Tingshu Wang
Explore and monitor how COVID-19 is affecting economies, industries and global issues
Get involved with our crowdsourced digital platform to deliver impact at scale
Stay up to date:
- New survey shows a majority of people would get a COVID-19 vaccine.
- But people are not optimistic that one is likely to be ready by the end of 2020.
- For those who wouldn’t get the vaccine, concern about side effects was the most commonly cited reason.
A new Ipsos survey, conducted on behalf of the World Economic Forum, shows that three-quarters of adults would get a vaccine for COVID-19 if it were available.
But nearly two-thirds (59%) don’t think one will be available by the end of 2020.
The study, which covers nearly 20,000 adults in 27 countries, also reveals where in the world take-up would be strongest.
Would you get a COVID-19 vaccine?
Of those surveyed, 74% strongly or somewhat agreed with the statement “if a vaccine for COVID-19 were available, I would get it”.
In China, this figure rose to 97%, but was lowest in Russia, Poland and Hungary.
If not, why not?
The survey also asked those who said they wouldn’t get the vaccine why they wouldn’t consider it.
Globally, 56% said they were worried about the side effects, 29% had concerns about its effectiveness and 17% said they were against vaccines in general.
But will it be ready?
Nearly 3 in 5 adults don’t think a vaccine will be available to them by the end of 2020.
But, as with interest in getting a vaccine, China stands out. Nearly 90% of those surveyed strongly or somewhat agreed a vaccine is likely to be ready.
Numerous pharmaceutical companies are working on vaccine trials and candidates, while organizations like the World Health Organization (WHO), Gavi and CEPI are also working to develop a vaccine and ensure any future solution is available for those most in need.
Dr Tedros Adhanom Ghebreyesus, WHO Director-General, has warned about the risks of “vaccine nationalism: “Sharing finite supplies strategically and globally is actually in each country's national interest,” he said in August, as he urged WHO Member States to join the COVID-19 Vaccines Global Access (COVAX) Facility.
Don't miss any update on this topic
Create a free account and access your personalized content collection with our latest publications and analyses.
License and Republishing
The views expressed in this article are those of the author alone and not the World Economic Forum.
More on COVID-19See all
January 8, 2024
October 11, 2023
August 8, 2023
Simon Nicholas Williams
May 9, 2023
Philip Clarke, Jack Pollard and Mara Violato
April 17, 2023